Literature DB >> 25576670

The diuresis clinic: a new paradigm for the treatment of mild decompensated heart failure.

Sunal Makadia1, Tanya Simmons2, Sharon Augustine2, Lara Kovell1, Che Harris1, Abednego Chibungu1, Kapil Parakh3.   

Abstract

BACKGROUND: Heart failure results in approximately 1 million hospital admissions annually in the United States and is the leading cause of 30-day readmissions.
METHODS: This study explores the impact of a diuresis clinic on heart failure outcomes and cost. Data were collected prospectively on all consecutive patients who received intravenous diuretics and multidisciplinary care in the clinic from its establishment from October 2011 to December 2012, as well as a comparison cohort of patients with heart failure who were admitted to the hospital for <48 hours. The percentage of hospitalized days was calculated for both cohorts 180 days before and 180 days after each patient's index visit.
RESULTS: In the diuresis clinic group, 106 patients (mean age, 68.2 ± 13 years; 48% were women) were treated over 328 visits (1-22 visits per person), with a mean intravenous furosemide dose of 100 mg, average urine output of 1460 ± 730 mL, and weight loss of 2.3 ± 1.8 kg. Days hospitalized decreased from 38.3 to 31.2 per 1000 patient-days after the index diuresis clinic visit (P < .01). In the comparison group, 143 patients (mean age, 69 ± 16 years; 54% were women) were admitted for <48 hours. Days hospitalized increased from 14.4 to 21.0 per 1000 patient-days after index admission (P < .01). On multivariate analysis, the diuresis clinic was associated with 3 fewer days in the hospital per 180 days per patient, with an estimated annual savings of $12,113 per patient.
CONCLUSIONS: Compared with a brief hospital stay, treatment of mild decompensated heart failure in a diuresis clinic resulted in a substantial and cost-effective decline in the rate of subsequent hospitalization.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Care delivery; Health innovation; Heart failure; Quality improvement

Mesh:

Substances:

Year:  2015        PMID: 25576670     DOI: 10.1016/j.amjmed.2014.11.028

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  12 in total

1.  Impact of Outpatient Diuretic Infusion Therapy on Healthcare Cost and Readmissions.

Authors:  Nandini Nair; Nandini Ray; Pavida Pachariyanon; Ryan Burden; Nicholas Skeen
Journal:  Int J Heart Fail       Date:  2022-01-11

2.  A Practical Way to Reduce Healthcare Costs in Patients With Heart Failure: Outpatient IV Diuretics Therapy.

Authors:  Mi-Hyang Jung
Journal:  Int J Heart Fail       Date:  2022-01-24

3.  Dilemmas in the Dosing of Heart Failure Drugs: Titrating Diuretics in Chronic Heart Failure.

Authors:  David Pham; Justin L Grodin
Journal:  Card Fail Rev       Date:  2017-11

4.  Outpatient Worsening Heart Failure as a Target for Therapy: A Review.

Authors:  Stephen J Greene; Robert J Mentz; G Michael Felker
Journal:  JAMA Cardiol       Date:  2018-03-01       Impact factor: 14.676

5.  A novel strategy to reduce the readmission rates in congestive heart failure: intermittent empirical intravenous diuretics.

Authors:  Ertan Yetkin; Bilal Cuglan; Hasan Turhan; Selcuk Ozturk
Journal:  Cardiovasc Endocrinol Metab       Date:  2020-05-15

6.  Outpatient Intravenous Diuretic Clinic: An Effective Strategy for Management of Volume Overload and Reducing Immediate Hospital Admissions.

Authors:  Vivek Verma; Manling Zhang; Marilyn Bell; Karen Tarolli; Elinor Donalson; Jamie Vaughn; Gavin W Hickey
Journal:  J Clin Med Res       Date:  2021-04-27

7.  The cost impact to Medicare of shifting treatment of worsening heart failure from inpatient to outpatient management settings.

Authors:  Kathryn Fitch; Jocelyn Lau; Tyler Engel; Joseph J Medicis; John F Mohr; William S Weintraub
Journal:  Clinicoecon Outcomes Res       Date:  2018-12-14

8.  Loop Diuretic Administration in Patients with Acute Heart Failure and Reduced Systolic Function: Effects of Different Intravenous Diuretic Doses and Diuretic Response Measurements.

Authors:  Gaetano Ruocco; Mauro Feola; Ranuccio Nuti; Lorenzo Luschi; Isabella Evangelista; Alberto Palazzuoli
Journal:  J Clin Med       Date:  2019-11-02       Impact factor: 4.241

9.  OUTpatient intravenous LASix Trial in reducing hospitalization for acute decompensated heart failure (OUTLAST).

Authors:  Carine E Hamo; Sahar S Abdelmoneim; Seol Young Han; Elizabeth Chandy; Cornelia Muntean; Saadat A Khan; Prasanthi Sunkesula; Marcella Meykler; Vidhya Ramachandran; Emelie Rosenberg; Igor Klem; Terrence J Sacchi; John F Heitner
Journal:  PLoS One       Date:  2021-06-25       Impact factor: 3.240

Review 10.  Outpatient treatment of worsening heart failure with intravenous and subcutaneous diuretics: a systematic review of the literature.

Authors:  Eric Wierda; Cathelijne Dickhoff; Martin Louis Handoko; Liane Oosterom; Wouter Emmanuel Kok; Y de Rover; B A J M de Mol; Loek van Heerebeek; Jutta Maria Schroeder-Tanka
Journal:  ESC Heart Fail       Date:  2020-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.